dc.contributor.author |
Torul, D. |
|
dc.contributor.author |
Cezairli, B. |
|
dc.contributor.author |
Kahveci, K. |
|
dc.date.accessioned |
2023-01-06T10:56:27Z |
|
dc.date.available |
2023-01-06T10:56:27Z |
|
dc.date.issued |
2021 |
|
dc.identifier.citation |
Torul, D., Cezairli, B., Kahveci, K. (2021). The efficacy of intra-articular injectable platelet-rich fibrin application in the management of Wilkes stage III temporomandibular joint internal derangement. International Journal of Oral and Maxillofacial Surgery, 50(11), 1485-1490.Doi:10.1016/j.ijom.2021.03.004 |
en_US |
dc.identifier.isbn |
0901-5027 |
|
dc.identifier.isbn |
1399-0020 |
|
dc.identifier.uri |
http://dx.doi.org/10.1016/j.ijom.2021.03.004 |
|
dc.identifier.uri |
https://www.webofscience.com/wos/woscc/full-record/WOS:000729202000013 |
|
dc.identifier.uri |
https://pubmed.ncbi.nlm.nih.gov/33771436 |
|
dc.identifier.uri |
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/3422 |
|
dc.description |
WoS Categories : Dentistry, Oral Surgery & Medicine; Surgery
Web of Science Index : Science Citation Index Expanded (SCI-EXPANDED)
Research Areas : Dentistry, Oral Surgery & Medicine; Surgery |
en_US |
dc.description.abstract |
The aim of this retrospective study was to compare the effectiveness of hyaluronic acid (HA) and injectable platelet-rich fibrin (i-PRF) in the management of Wilkes stage III internal derangement, and to evaluate the biosupplementation capacity of i-PRF. The records of all 54 relevant patients with Wilkes stage III internal derangement confirmed by magnetic resonance imaging and treated with arthrocentesis alone or in combination with HA or i-PRF were selected. The outcome variables were pain intensity at rest (VASr) and in function (VASf), evaluated with a visual analogue scale, and maximum mouth opening (MMO), evaluated in millimetres; assessments were made preoperatively, immediately after the procedure, and at 1 week, 1 month, and 3 months postoperatively. When compared to the HA and arthrocentesis groups, the i-PRF group showed significantly better improvements in MMO at 1 and 3 months (P = 0.024 and P = 0.006, respectively), VASr at 1 and 3 months (both P < 0.001), and VASf at 1 week (P = 0.019) and 1 and 3 months (both P < 0.001) postoperatively. In all groups, better MMO, VASr, and VASf values were observed compared to the preoperative status. The application of i-PRF after arthrocentesis is more effective than arthrocentesis alone or with HA in the short term. HA was found not to provide significant additional benefits over arthrocentesis alone. |
en_US |
dc.language.iso |
eng |
en_US |
dc.publisher |
CHURCHILL LIVINGSTONE EDINBURGH |
en_US |
dc.relation.isversionof |
10.1016/j.ijom.2021.03.004 |
en_US |
dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
dc.subject |
PLUS HYALURONIC-ACID; SODIUM HYALURONATE; PLASMA INJECTION; DISC DISPLACEMENT; GROWTH-FACTORS; ARTHROCENTESIS; OSTEOARTHRITIS; ARTHROSCOPY; TENOXICAM; SUPERIOR |
en_US |
dc.subject |
arthrocentesis; temporomandibular joint disorders; temporomandibular joint; degenerative; platelet-rich fibrin |
en_US |
dc.title |
The efficacy of intra-articular injectable platelet-rich fibrin application in the management of Wilkes stage III temporomandibular joint internal derangement |
en_US |
dc.type |
article |
en_US |
dc.relation.journal |
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY |
en_US |
dc.contributor.department |
Ordu Üniversitesi |
en_US |
dc.contributor.authorID |
0000-0003-2323-606X |
en_US |
dc.contributor.authorID |
0000-0001-8532-3367 |
en_US |
dc.identifier.volume |
50 |
en_US |
dc.identifier.issue |
11 |
en_US |
dc.identifier.startpage |
1485 |
en_US |
dc.identifier.endpage |
1490 |
en_US |